TY - CHAP A1 - Camil Ciprian Mirestean A2 - Călin Gheorghe Buzea A3 - Roxana Irina Iancu A4 - Dragoș Petru Teodor Iancu ED1 - Sivapatham Sundaresan ED2 - Yeun-Hwa Gu Y1 - 2021-02-03 PY - 2021 T1 - Implications of Radiosensitizer and Radioprotector Factors in Refining the Dose-Volume Constraints and Radiobiological Models N2 - Translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies concerning the molecular pathways involved in tumorigenesis. Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. The vast majority of cancer cases are due to environmental risk factors. Many of these environmental factors are controllable lifestyle choices. Experimental cancer treatments are studied in clinical trials to compare the proposed treatment to the best existing treatment through translational research. The key features of the book include: 1) New screening for the development of radioprotectors: radioprotection and anti-cancer effect of β-Glucan (Enterococcus faecalis) 2) Translational perspective on hepatocellular carcinoma 3) Brachytherapy for endometrial cancer 4) Discovery of small molecule inhibitors for histone methyltransferases in cancer BT - Translational Research in Cancer SP - Ch. 12 UR - https://doi.org/10.5772/intechopen.89829 DO - 10.5772/intechopen.89829 SN - 978-1-83880-535-7 PB - IntechOpen CY - Rijeka Y2 - 2021-04-22 ER -